TRAX First Tracks Biotherapeutics, Inc.
30.59USD-2.55%Mkt Cap: 1.09B $P/E: —1d ago
First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a …
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap1.09B USD
Enterprise Value957.91M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-163.71M USD
Revenue/Share—
Last Price30.59 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees104
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.76
PEG—
EV/EBITDA-5.67
EV/Revenue—
P/S—
P/B6.58
EPS (TTM)-4.71
EPS (Forward)-3.58
52W Range
14.7945% of range49.91
52W High49.91 USD
52W Low14.79 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-41.80%
ROA-37.05%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-125.81M USD
CapEx (TTM)358.00K USD
FCF Margin—
FCF Yield—
Net Debt-163.69M USD
Net Debt/EBITDA0.97
Balance Sheet
Debt/Equity0.04
Current Ratio14.28
Quick Ratio13.91
Book Value/Sh4.77 USD
Cash/Share4.70 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)70.00 USD
Upside (mean)+128.8%
Target Range50.00 USD – 100.00 USD
50.00+128.8% to mean100.00
# Analysts12
Ownership
Shares Out.35.73M
Float26.15M
Insiders8.75%
Institutions100.96%
Short Interest
Short Ratio7.7d
Short % Out.12.59%
Shares Short4.50M
Short (prev mo.)3.89M
Technical
SMA 5041.37 (-26.1%)
SMA 20029.35 (+4.2%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)692.04K
Avg Vol (10d)738.26K
Technical Indicators
RSI (14)31.4
MACD-2.2810
MACD Signal-1.6872
MACD Hist.-0.5938
BB Upper41.78 USD
BB Middle36.22 USD
BB Lower30.66 USD
BB Width30.71%
ATR (14)2.704 USD
Vol Ratio (20d)0.48x